🇺🇸 FDA
Company

Viking

Viking Therapeutics

VKTX pharma USA

Quick answer

Viking is a pharma company (VKTX) headquartered in SAN DIEGO, CA, USA with 6 tracked pipeline programs.

Pipeline (6)

project

VK2735

Weight Loss

Phase 3 · small_molecule · active

4 trials project

Placebo

Weight Loss

Phase 2 · small_molecule · completed

1 trials project

VK2809

Hyperlipidemia

Phase 2 · small_molecule · completed

1 trials project

VK2809

NASH - Nonalcoholic Steatohepatitis

Phase 2 · small_molecule · completed

1 trials project

VK5211

Hip Fractures

Phase 2 · small_molecule · completed

1 trials project

VK0214

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12421282

Compositions and methods for the treatment of metabolic and liver disorders

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12318426

Compositions and methods for the treatment of metabolic and liver disorders

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12102646

Compositions for the treatment of fibrosis and inflammation

Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12083184

Hydrogel prodrug for treatment

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11951114

Use of thyroid beta-agonists

Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11752217

Hydrogel prodrug for treatment

Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11744873

Compositions and methods for the treatment of metabolic and liver disorders

Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11707472

Compositions for the treatment of fibrosis

Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)